chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain
Clinical narrative: Woke up at 01:00 with severe body aches; was hard to walk or move; cold sweats; Chills; fever of 100.3 F; This is a spontaneous report from a contactable nurse reported for herself. A 42-years-old female patient received second dose of bnt162b2 (BNT162B2), intramuscular on 14Jan2021 10:00 at single dose on left arm for covid-19 immunisation. The patient medical history was not reported. The patient had no allergies to medications, food, or other products. Concomitant medication included lisdexamfetamine mesilate (VYVANSE), clonazepam (KLONOPIN), quetiapine fumarate (SEROQUEL), aspirin [acetylsalicylic acid] (ASPIRIN). The patient received first dose of COVID 19 for covid-19 immunisation at 42-years-old, lot unknown=False, administration date=on 24Dec2020 09:00 AM, administrator route=Intramuscular, vaccine location=Left arm. The patient experienced woke up at 01:00 with severe body aches, was hard to walk or move, cold sweats, chills, fever of 100.3 f on 15Jan2021 13:00. Lab data included body temperature 100.3 f on 15Jan2021 13:00. The event outcome was recovering. No treatment was received for the adverse event. The events were reported as non-serious. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  Information on the lot/batch number has been requested.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Body temperature, Chills, Cold sweat, Gait disturbance, Pain
Clinical narrative: Woke up at 01:00 with severe body aches; was hard to walk or move; cold sweats; Chills; fever of 100.3 F; This is a spontaneous report from a contactable nurse reported for herself. A 42-years-old female patient received second dose of bnt162b2 (BNT162B2), intramuscular on 14Jan2021 10:00 at single dose on left arm for covid-19 immunisation. The patient medical history was not reported. The patient had no allergies to medications, food, or other products. Concomitant medication included lisdexamfetamine mesilate (VYVANSE), clonazepam (KLONOPIN), quetiapine fumarate (SEROQUEL), aspirin [acetylsalicylic acid] (ASPIRIN). The patient received first dose of COVID 19 for covid-19 immunisation at 42-years-old, lot unknown=False, administration date=on 24Dec2020 09:00 AM, administrator route=Intramuscular, vaccine location=Left arm. The patient experienced woke up at 01:00 with severe body aches, was hard to walk or move, cold sweats, chills, fever of 100.3 f on 15Jan2021 13:00. Lab data included body temperature 100.3 f on 15Jan2021 13:00. The event outcome was recovering. No treatment was received for the adverse event. The events were reported as non-serious. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  Information on the lot/batch number has been requested.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia
Clinical narrative: Woke up at 01:00 with severe body aches; was hard to walk or move; cold sweats; Chills; fever of 100.3 F; This is a spontaneous report from a contactable nurse reported for herself. A 42-years-old female patient received second dose of bnt162b2 (BNT162B2), intramuscular on 14Jan2021 10:00 at single dose on left arm for covid-19 immunisation. The patient medical history was not reported. The patient had no allergies to medications, food, or other products. Concomitant medication included lisdexamfetamine mesilate (VYVANSE), clonazepam (KLONOPIN), quetiapine fumarate (SEROQUEL), aspirin [acetylsalicylic acid] (ASPIRIN). The patient received first dose of COVID 19 for covid-19 immunisation at 42-years-old, lot unknown=False, administration date=on 24Dec2020 09:00 AM, administrator route=Intramuscular, vaccine location=Left arm. The patient experienced woke up at 01:00 with severe body aches, was hard to walk or move, cold sweats, chills, fever of 100.3 f on 15Jan2021 13:00. Lab data included body temperature 100.3 f on 15Jan2021 13:00. The event outcome was recovering. No treatment was received for the adverse event. The events were reported as non-serious. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  Information on the lot/batch number has been requested.
Age: 24.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Heart rate increased
Clinical narrative: c/o tachycardia. "My heart feels like it's racing." c/o throat feeling dry. HR = 125bpm; epi-pen x1; oxygen initiated; transferred to higher level of care
Age: 24.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dry throat, Palpitations, Tachycardia
Clinical narrative: c/o tachycardia. "My heart feels like it's racing." c/o throat feeling dry. HR = 125bpm; epi-pen x1; oxygen initiated; transferred to higher level of care
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dysgeusia, Hypoaesthesia oral, Palate injury, Tension
Clinical narrative: metallic taste in mouth (went away with sleep and gone with wake up)/metallic taste in mouth came back; Muscle tension in left neck area and left upper back; This is a spontaneous report from a contactable other health professional (reporting for herself). A 35-year-old female patient received, BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), LOT number: EL 3247 via an unspecified route of administration, on 13Jan2021 15:15 at a single dose, for covid-19 immunization.  The patient's medical history was not reported.  Concomitant medication included sertraline.  On 13Jan2021 15:20 The patient experienced muscle tension in left neck area and left upper back.  On the 1st day after vaccination (14Jan2021 21:15), patient experienced metallic taste in mouth which went away with sleep and gone with wake up but on 2nd day after vaccination 15Jan2021 at 7:30, metallic taste in mouth came back. The outcome of events was not recovered. Patient did not received treatment due to the events. Events were considered non-serious.  No follow-up attempts are possible. No further information is expected. Information on the lot/batch number has been obtained.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dysgeusia, Muscle tightness
Clinical narrative: metallic taste in mouth (went away with sleep and gone with wake up)/metallic taste in mouth came back; Muscle tension in left neck area and left upper back; This is a spontaneous report from a contactable other health professional (reporting for herself). A 35-year-old female patient received, BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), LOT number: EL 3247 via an unspecified route of administration, on 13Jan2021 15:15 at a single dose, for covid-19 immunization.  The patient's medical history was not reported.  Concomitant medication included sertraline.  On 13Jan2021 15:20 The patient experienced muscle tension in left neck area and left upper back.  On the 1st day after vaccination (14Jan2021 21:15), patient experienced metallic taste in mouth which went away with sleep and gone with wake up but on 2nd day after vaccination 15Jan2021 at 7:30, metallic taste in mouth came back. The outcome of events was not recovered. Patient did not received treatment due to the events. Events were considered non-serious.  No follow-up attempts are possible. No further information is expected. Information on the lot/batch number has been obtained.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cholecystitis, Dyspnoea, Pain
Clinical narrative: Pt presented to my clinic 1/25/2021 in 9/10 RUQ abd pain, which began within 24 H of vaccine administration; labs pending
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain upper, Laboratory test
Clinical narrative: Pt presented to my clinic 1/25/2021 in 9/10 RUQ abd pain, which began within 24 H of vaccine administration; labs pending
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test normal, Blood thyroid stimulating hormone, Blood uric acid normal, C-reactive protein increased, Full blood count normal
Clinical narrative: muscle stiffness; joint rigidity; Inability to change positions, sit to stand or stand to sit; Inability to walk; inflammation; This is a spontaneous report from a contactable nurse (patient). A 34-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH9899), via an unspecified route of administration in right arm on 22Dec2020 09:15 at single dose for COVID-19 immunization. Medical history included hypothyroidism related to thyroid ablation and obesity from an unknown date and unknown if ongoing. Concomitant medication included levothyroxine sodium (SYNTHROID). On 24Dec2020 10:30 PM, the patient experienced extreme muscle stiffness and joint rigidity, inability to change positions, sit to stand or stand to sit, inability to walk and ended up getting several labs completed and all but 1 was normal and it only showed inflammation. The patient had to do a prednisone taper and go on Meloxicam in order to resume working and daily activities. The events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The events was treated with prednisone and Meloxicam. The patient was not pregnant. The facility where the most recent COVID-19 vaccine was administered was in the hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19, nasal swab test: negative on 29Dec2020. The outcome of the events was not recovered.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Gait disturbance, Joint stiffness, Metabolic function test normal, Mobility decreased, Muscle tightness
Clinical narrative: muscle stiffness; joint rigidity; Inability to change positions, sit to stand or stand to sit; Inability to walk; inflammation; This is a spontaneous report from a contactable nurse (patient). A 34-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH9899), via an unspecified route of administration in right arm on 22Dec2020 09:15 at single dose for COVID-19 immunization. Medical history included hypothyroidism related to thyroid ablation and obesity from an unknown date and unknown if ongoing. Concomitant medication included levothyroxine sodium (SYNTHROID). On 24Dec2020 10:30 PM, the patient experienced extreme muscle stiffness and joint rigidity, inability to change positions, sit to stand or stand to sit, inability to walk and ended up getting several labs completed and all but 1 was normal and it only showed inflammation. The patient had to do a prednisone taper and go on Meloxicam in order to resume working and daily activities. The events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The events was treated with prednisone and Meloxicam. The patient was not pregnant. The facility where the most recent COVID-19 vaccine was administered was in the hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19, nasal swab test: negative on 29Dec2020. The outcome of the events was not recovered.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity, Rheumatoid factor, Streptococcus test
Clinical narrative: muscle stiffness; joint rigidity; Inability to change positions, sit to stand or stand to sit; Inability to walk; inflammation; This is a spontaneous report from a contactable nurse (patient). A 34-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH9899), via an unspecified route of administration in right arm on 22Dec2020 09:15 at single dose for COVID-19 immunization. Medical history included hypothyroidism related to thyroid ablation and obesity from an unknown date and unknown if ongoing. Concomitant medication included levothyroxine sodium (SYNTHROID). On 24Dec2020 10:30 PM, the patient experienced extreme muscle stiffness and joint rigidity, inability to change positions, sit to stand or stand to sit, inability to walk and ended up getting several labs completed and all but 1 was normal and it only showed inflammation. The patient had to do a prednisone taper and go on Meloxicam in order to resume working and daily activities. The events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The events was treated with prednisone and Meloxicam. The patient was not pregnant. The facility where the most recent COVID-19 vaccine was administered was in the hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19, nasal swab test: negative on 29Dec2020. The outcome of the events was not recovered.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Gait disturbance, Inflammation, Investigation, Joint stiffness, Mobility decreased
Clinical narrative: muscle stiffness; joint rigidity; Inability to change positions, sit to stand or stand to sit; Inability to walk; inflammation; This is a spontaneous report from a contactable nurse (patient). A 34-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH9899), via an unspecified route of administration in right arm on 22Dec2020 09:15 at single dose for COVID-19 immunization. Medical history included hypothyroidism related to thyroid ablation and obesity from an unknown date and unknown if ongoing. Concomitant medication included levothyroxine sodium (SYNTHROID). On 24Dec2020 10:30 PM, the patient experienced extreme muscle stiffness and joint rigidity, inability to change positions, sit to stand or stand to sit, inability to walk and ended up getting several labs completed and all but 1 was normal and it only showed inflammation. The patient had to do a prednisone taper and go on Meloxicam in order to resume working and daily activities. The events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The events was treated with prednisone and Meloxicam. The patient was not pregnant. The facility where the most recent COVID-19 vaccine was administered was in the hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19, nasal swab test: negative on 29Dec2020. The outcome of the events was not recovered.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Musculoskeletal stiffness, SARS-CoV-2 antibody test
Clinical narrative: muscle stiffness; joint rigidity; Inability to change positions, sit to stand or stand to sit; Inability to walk; inflammation; This is a spontaneous report from a contactable nurse (patient). A 34-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH9899), via an unspecified route of administration in right arm on 22Dec2020 09:15 at single dose for COVID-19 immunization. Medical history included hypothyroidism related to thyroid ablation and obesity from an unknown date and unknown if ongoing. Concomitant medication included levothyroxine sodium (SYNTHROID). On 24Dec2020 10:30 PM, the patient experienced extreme muscle stiffness and joint rigidity, inability to change positions, sit to stand or stand to sit, inability to walk and ended up getting several labs completed and all but 1 was normal and it only showed inflammation. The patient had to do a prednisone taper and go on Meloxicam in order to resume working and daily activities. The events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The events was treated with prednisone and Meloxicam. The patient was not pregnant. The facility where the most recent COVID-19 vaccine was administered was in the hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19, nasal swab test: negative on 29Dec2020. The outcome of the events was not recovered.
Age: 22.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anxiety, Dizziness, Pruritus, Rash
Clinical narrative: PATIENT DEVELOPED HIVES ON B/L PALM WITH LIGHTHEADEDNESS WITHIN 15MIN POST 2ND VACCINE OF PFIZER BIONTECH VACCINE. SHE WAS GIVEN EPIPEN ON SITE. SHE WENT HOME AND YET AGAIN DEVELOPED RASH ON PALMS. SHE WENT TO ER THAT NIGHT 1/17/2021. SHE FELT EXTREME FATIGUE, NAUSEA, CHILLS AND FEVER ON WEDNESDAY 01/20/2021 AND WENT TO THE ER ONCE AGAIN THAT NIGHT.
Age: 22.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Dizziness, Fatigue, Immediate post-injection reaction, Nausea
Clinical narrative: PATIENT DEVELOPED HIVES ON B/L PALM WITH LIGHTHEADEDNESS WITHIN 15MIN POST 2ND VACCINE OF PFIZER BIONTECH VACCINE. SHE WAS GIVEN EPIPEN ON SITE. SHE WENT HOME AND YET AGAIN DEVELOPED RASH ON PALMS. SHE WENT TO ER THAT NIGHT 1/17/2021. SHE FELT EXTREME FATIGUE, NAUSEA, CHILLS AND FEVER ON WEDNESDAY 01/20/2021 AND WENT TO THE ER ONCE AGAIN THAT NIGHT.
Age: 22.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia, Rash, Urticaria
Clinical narrative: PATIENT DEVELOPED HIVES ON B/L PALM WITH LIGHTHEADEDNESS WITHIN 15MIN POST 2ND VACCINE OF PFIZER BIONTECH VACCINE. SHE WAS GIVEN EPIPEN ON SITE. SHE WENT HOME AND YET AGAIN DEVELOPED RASH ON PALMS. SHE WENT TO ER THAT NIGHT 1/17/2021. SHE FELT EXTREME FATIGUE, NAUSEA, CHILLS AND FEVER ON WEDNESDAY 01/20/2021 AND WENT TO THE ER ONCE AGAIN THAT NIGHT.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Back pain, Neck pain, Pain
Clinical narrative: 12 hours after the second dose I experienced body aches, low grade fever for about 6 hours.  After that I had upper and lower back pain, neck pain and a mild headache.; 12 hours after the second dose I experienced body aches, low grade fever for about 6 hours.  After that I had upper and lower back pain, neck pain and a mild headache.; 12 hours after the second dose I experienced body aches, low grade fever for about 6 hours.  After that I had upper and lower back pain, neck pain and a mild headache.; 12 hours after the second dose I experienced body aches, low grade fever for about 6 hours.  After that I had upper and lower back pain, neck pain and a mild headache.; 12 hours after the second dose I experienced body aches, low grade fever for about 6 hours.  After that I had upper and lower back pain, neck pain and a mild headache.; breastfeeding; breastfeeding; This is a spontaneous report from a contactable other healthcare professional (HCP). The reporter reported for herself and her child. This is the mother report.   A 39-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EK9231), via an unspecified route of administration on 08Jan2021 at a SINGLE DOSE for covid-19 immunisation. Medical history included breast feeding from an unknown date and unknown if ongoing. The patient previously took BNT162B2 on 18Dec2020. The patient stated on 08Jan2021, 12 hours after the second dose, she experienced body aches, low grade fever for about 6 hours. After that she had upper and lower back pain, neck pain and a mild headache. She took Advil and felt normal shortly after for the rest of the day and there after. She would categorize my symptoms as mild. The outcome of the events was recovered.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021030867 Parent/fetus cases.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Back pain, Headache, Neck pain, Off label use, Pain
Clinical narrative: 12 hours after the second dose I experienced body aches, low grade fever for about 6 hours.  After that I had upper and lower back pain, neck pain and a mild headache.; 12 hours after the second dose I experienced body aches, low grade fever for about 6 hours.  After that I had upper and lower back pain, neck pain and a mild headache.; 12 hours after the second dose I experienced body aches, low grade fever for about 6 hours.  After that I had upper and lower back pain, neck pain and a mild headache.; 12 hours after the second dose I experienced body aches, low grade fever for about 6 hours.  After that I had upper and lower back pain, neck pain and a mild headache.; 12 hours after the second dose I experienced body aches, low grade fever for about 6 hours.  After that I had upper and lower back pain, neck pain and a mild headache.; breastfeeding; breastfeeding; This is a spontaneous report from a contactable other healthcare professional (HCP). The reporter reported for herself and her child. This is the mother report.   A 39-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EK9231), via an unspecified route of administration on 08Jan2021 at a SINGLE DOSE for covid-19 immunisation. Medical history included breast feeding from an unknown date and unknown if ongoing. The patient previously took BNT162B2 on 18Dec2020. The patient stated on 08Jan2021, 12 hours after the second dose, she experienced body aches, low grade fever for about 6 hours. After that she had upper and lower back pain, neck pain and a mild headache. She took Advil and felt normal shortly after for the rest of the day and there after. She would categorize my symptoms as mild. The outcome of the events was recovered.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021030867 Parent/fetus cases.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Product use issue, Pyrexia
Clinical narrative: 12 hours after the second dose I experienced body aches, low grade fever for about 6 hours.  After that I had upper and lower back pain, neck pain and a mild headache.; 12 hours after the second dose I experienced body aches, low grade fever for about 6 hours.  After that I had upper and lower back pain, neck pain and a mild headache.; 12 hours after the second dose I experienced body aches, low grade fever for about 6 hours.  After that I had upper and lower back pain, neck pain and a mild headache.; 12 hours after the second dose I experienced body aches, low grade fever for about 6 hours.  After that I had upper and lower back pain, neck pain and a mild headache.; 12 hours after the second dose I experienced body aches, low grade fever for about 6 hours.  After that I had upper and lower back pain, neck pain and a mild headache.; breastfeeding; breastfeeding; This is a spontaneous report from a contactable other healthcare professional (HCP). The reporter reported for herself and her child. This is the mother report.   A 39-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EK9231), via an unspecified route of administration on 08Jan2021 at a SINGLE DOSE for covid-19 immunisation. Medical history included breast feeding from an unknown date and unknown if ongoing. The patient previously took BNT162B2 on 18Dec2020. The patient stated on 08Jan2021, 12 hours after the second dose, she experienced body aches, low grade fever for about 6 hours. After that she had upper and lower back pain, neck pain and a mild headache. She took Advil and felt normal shortly after for the rest of the day and there after. She would categorize my symptoms as mild. The outcome of the events was recovered.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021030867 Parent/fetus cases.
Age: 18.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Nervousness
Clinical narrative: In addition to report # 250652.  Patient stated on 1/21/21 they went to ER.  Starting the night of 1/20/21 patient reported pins/needles feelings in random locations of body and extreme head pressure (8/10).  On 1/21/21 she went to ER with limb weakness in addition to pins/needles.  Upon exam in ER they found nothing but suggested completing and VAERS report.
Age: 18.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Head discomfort, Muscular weakness, Paraesthesia
Clinical narrative: In addition to report # 250652.  Patient stated on 1/21/21 they went to ER.  Starting the night of 1/20/21 patient reported pins/needles feelings in random locations of body and extreme head pressure (8/10).  On 1/21/21 she went to ER with limb weakness in addition to pins/needles.  Upon exam in ER they found nothing but suggested completing and VAERS report.
Age: 18.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Abdominal pain upper, Blood test normal, Crying, Dizziness, Head discomfort
Clinical narrative: In addition to report # 250652.  Patient stated on 1/21/21 they went to ER.  Starting the night of 1/20/21 patient reported pins/needles feelings in random locations of body and extreme head pressure (8/10).  On 1/21/21 she went to ER with limb weakness in addition to pins/needles.  Upon exam in ER they found nothing but suggested completing and VAERS report.
Age: 18.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Immediate post-injection reaction, Muscular weakness, Musculoskeletal stiffness, Neuralgia
Clinical narrative: In addition to report # 250652.  Patient stated on 1/21/21 they went to ER.  Starting the night of 1/20/21 patient reported pins/needles feelings in random locations of body and extreme head pressure (8/10).  On 1/21/21 she went to ER with limb weakness in addition to pins/needles.  Upon exam in ER they found nothing but suggested completing and VAERS report.
Age: 24.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anxiety, Palpitations
Clinical narrative: On 1/24, severe axillary lymph node pain occurred ipsilateral to injection site and has been continuous. On 1/26, 1in x 2in swollen, smooth, rash formed near injection site.
Age: 24.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Axillary pain, Injection site rash, Injection site swelling, Lymph node pain
Clinical narrative: On 1/24, severe axillary lymph node pain occurred ipsilateral to injection site and has been continuous. On 1/26, 1in x 2in swollen, smooth, rash formed near injection site.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anaphylactic reaction, Dizziness, Throat tightness, Urticaria
Clinical narrative: Roughly 25 minutes after getting vaccine I passed out and when I came to my throat felt like it was closing and I was very itchy on my neck and chest . Had hives
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Loss of consciousness, Pruritus, Throat tightness, Urticaria
Clinical narrative: Roughly 25 minutes after getting vaccine I passed out and when I came to my throat felt like it was closing and I was very itchy on my neck and chest . Had hives
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dysphagia, Throat tightness
Clinical narrative: At 08:15, first response was called to tend to a hospital employee at the vaccine clinic as she was unable to swallow and disclosed that she self-medicated using Benadryl 2 hours after her first COVID vaccine d/t symptoms of "scratchy throat"   She did not say "yes" to any of the consent questions prior to administration of 2nd vaccine dose to indicate any concerns. Symptoms progressed to difficulty breathing within a few min. and 25 mg of Benadryl IM and Epi 1mg SQ was given on-site.   The employee was subsequently transferred to ED at 08:40 am.  She was given Decadron 10 mg IV and Famotidine discharged home.  Today 1/26, her wheezing/stridor persist and she has schedule to f/u w/ her PCP.
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dysphagia, Dyspnoea, Oropharyngeal discomfort, Stridor, Wheezing
Clinical narrative: At 08:15, first response was called to tend to a hospital employee at the vaccine clinic as she was unable to swallow and disclosed that she self-medicated using Benadryl 2 hours after her first COVID vaccine d/t symptoms of "scratchy throat"   She did not say "yes" to any of the consent questions prior to administration of 2nd vaccine dose to indicate any concerns. Symptoms progressed to difficulty breathing within a few min. and 25 mg of Benadryl IM and Epi 1mg SQ was given on-site.   The employee was subsequently transferred to ED at 08:40 am.  She was given Decadron 10 mg IV and Famotidine discharged home.  Today 1/26, her wheezing/stridor persist and she has schedule to f/u w/ her PCP.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Death, Headache, Injection site pain, Vomiting
Clinical narrative: Vaccine given on 1/19, on 1/20 headache and vomiting plus sore arm
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Pain in extremity, Vomiting
Clinical narrative: Vaccine given on 1/19, on 1/20 headache and vomiting plus sore arm
Age: 30.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Bilevel positive airway pressure, Bladder catheterisation, Blood potassium decreased, Dyspnoea, Endotracheal intubation
Clinical narrative: Anaphylaxis. Intubated. still in ICU as of 1/26/21 on epi drip, IV H2 blocker, decadron, beandry and still having "waves:" of bronchoconstriction and stridor requiring racemic epi
Age: 30.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Gastrointestinal tube insertion, Intensive care, Sinus tachycardia, Stridor, Wheezing
Clinical narrative: Anaphylaxis. Intubated. still in ICU as of 1/26/21 on epi drip, IV H2 blocker, decadron, beandry and still having "waves:" of bronchoconstriction and stridor requiring racemic epi
Age: 30.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Anaphylactic reaction, Bronchospasm, Endotracheal intubation, Intensive care, Stridor
Clinical narrative: Anaphylaxis. Intubated. still in ICU as of 1/26/21 on epi drip, IV H2 blocker, decadron, beandry and still having "waves:" of bronchoconstriction and stridor requiring racemic epi
Age: 25.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Computerised tomogram head normal, Facial pain, Hemiplegia, Magnetic resonance imaging brain normal, Magnetic resonance imaging neck
Clinical narrative: Patient is a 25-year-old female past medical history of GERD, ADHD, asthma, migraines, SVT who has been admitted for right-sided weakness.  Patient presented to the ER as an allergic reaction to the COVID-19 vaccine that she received earlier in the morning prior to admission symptoms started approximately 3 hours later.  Patient reported checking her pulse at home which was found to be 170 she reported trying vagal maneuvers which decreased her heart rate to 110s.  patient reported feeling pressure in her right arm as well as numbness in her right arm facial pain double vision and right-sided numbness that extended down to her toes as well as pain that she rates as 6/10.  Patient reports that she now feels unable to walk due to her right-sided weakness.
Age: 25.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain
Clinical narrative: Patient is a 25-year-old female past medical history of GERD, ADHD, asthma, migraines, SVT who has been admitted for right-sided weakness.  Patient presented to the ER as an allergic reaction to the COVID-19 vaccine that she received earlier in the morning prior to admission symptoms started approximately 3 hours later.  Patient reported checking her pulse at home which was found to be 170 she reported trying vagal maneuvers which decreased her heart rate to 110s.  patient reported feeling pressure in her right arm as well as numbness in her right arm facial pain double vision and right-sided numbness that extended down to her toes as well as pain that she rates as 6/10.  Patient reports that she now feels unable to walk due to her right-sided weakness.
Age: 25.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Diplopia, Facial pain, Gait inability, Heart rate increased, Hemiparesis
Clinical narrative: Patient is a 25-year-old female past medical history of GERD, ADHD, asthma, migraines, SVT who has been admitted for right-sided weakness.  Patient presented to the ER as an allergic reaction to the COVID-19 vaccine that she received earlier in the morning prior to admission symptoms started approximately 3 hours later.  Patient reported checking her pulse at home which was found to be 170 she reported trying vagal maneuvers which decreased her heart rate to 110s.  patient reported feeling pressure in her right arm as well as numbness in her right arm facial pain double vision and right-sided numbness that extended down to her toes as well as pain that she rates as 6/10.  Patient reports that she now feels unable to walk due to her right-sided weakness.
Age: 25.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypersensitivity, Hypoaesthesia, Limb discomfort, Pain
Clinical narrative: Patient is a 25-year-old female past medical history of GERD, ADHD, asthma, migraines, SVT who has been admitted for right-sided weakness.  Patient presented to the ER as an allergic reaction to the COVID-19 vaccine that she received earlier in the morning prior to admission symptoms started approximately 3 hours later.  Patient reported checking her pulse at home which was found to be 170 she reported trying vagal maneuvers which decreased her heart rate to 110s.  patient reported feeling pressure in her right arm as well as numbness in her right arm facial pain double vision and right-sided numbness that extended down to her toes as well as pain that she rates as 6/10.  Patient reports that she now feels unable to walk due to her right-sided weakness.
Age: 85.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Dyspnoea, Electrocardiogram
Clinical narrative: Shortness of breath--Transferred to Advanced Urgent Care, EKG and BW completed.  Symptoms resolved and discharged with no treatment.
Age: 85.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood test, Dyspnoea, Electrocardiogram
Clinical narrative: Shortness of breath--Transferred to Advanced Urgent Care, EKG and BW completed.  Symptoms resolved and discharged with no treatment.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Abortion spontaneous, Exposure during pregnancy, Ultrasound scan abnormal
Clinical narrative: Systemic: Other- Patient was pregnant at time of vaccination, patient miscarried the day following first dose-Severe; symptoms lasted 1 day
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: No adverse event
Clinical narrative: Systemic: Other- Patient was pregnant at time of vaccination, patient miscarried the day following first dose-Severe; symptoms lasted 1 day
Age: 23.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chest pain, Echocardiogram normal, Electrocardiogram PR segment depression, Electrocardiogram ST segment elevation, Myocarditis
Clinical narrative: 1/22/2021 client reported chest pain. ER visit revealed elevated troponin level, abnormal EKG. Client admitted 1/22/2021 and discharged 1/24/21.
Age: 23.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pericarditis, Troponin increased
Clinical narrative: 1/22/2021 client reported chest pain. ER visit revealed elevated troponin level, abnormal EKG. Client admitted 1/22/2021 and discharged 1/24/21.
Age: 23.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chest pain, Electrocardiogram abnormal, Myocarditis, Troponin increased
Clinical narrative: 1/22/2021 client reported chest pain. ER visit revealed elevated troponin level, abnormal EKG. Client admitted 1/22/2021 and discharged 1/24/21.
Age: 23.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Cough, Discomfort, Myocarditis, Oropharyngeal pain, Wheezing
Clinical narrative: 1/22/2021 client reported chest pain. ER visit revealed elevated troponin level, abnormal EKG. Client admitted 1/22/2021 and discharged 1/24/21.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Muscle spasms
Clinical narrative: Little sore; This is a spontaneous report from a contactable consumer (patient).  A 59-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunisation.  Medical history included ongoing crohn's disease.  The patient's concomitant medications were not reported.  The patient experienced little sore on an unspecified date. Therapeutic measures taken as a result of little sore was treatment with IBUPROFEN. The outcome was unknown.    The information on the batch/lot number has been requested.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Myalgia
Clinical narrative: Little sore; This is a spontaneous report from a contactable consumer (patient).  A 59-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunisation.  Medical history included ongoing crohn's disease.  The patient's concomitant medications were not reported.  The patient experienced little sore on an unspecified date. Therapeutic measures taken as a result of little sore was treatment with IBUPROFEN. The outcome was unknown.    The information on the batch/lot number has been requested.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pain
Clinical narrative: Little sore; This is a spontaneous report from a contactable consumer (patient).  A 59-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunisation.  Medical history included ongoing crohn's disease.  The patient's concomitant medications were not reported.  The patient experienced little sore on an unspecified date. Therapeutic measures taken as a result of little sore was treatment with IBUPROFEN. The outcome was unknown.    The information on the batch/lot number has been requested.
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Urticaria
Clinical narrative: Started breaking out in hives; This is a spontaneous report from a contactable consumer (patient). A 29-year-old female patient received the first dose of BNT162B2, lot number: EL0142, via an unspecified route of administration on 30Dec2020 at single dose for COVID-19 immunisation. Medical history included asthma (had an Inhaler just for whenever it's bad but she hadn't taken it in probably over a year), had typhoid once in the past as a child and had an allergy to Sulfa drugs (Unspecified Medication). The patient's concomitant medications were not reported. Patient stated she got the Vaccine on 30Dec2020 and a week later that would have been on 06Jan2021, she believed that was the date that evening she started breaking out in hives and she typically had typhoid once in the past as a child because she had an allergy to Sulfa drugs (Unspecified Medication). So she got hives a week later and she got them again three days later both in the evening and both disappeared by the time. She woke up in the morning she didn't take any antihistamines or anything. The patient wanted to know if that was a reaction other people were having and could provide any advice on second dose. She was supposed to get the second dose on the 21Jan2021. Patient stated it was twice that she had received the vaccine, she broke out with hives and it was not typically normal for her. The patient had lab testing a couple of weeks prior to the report, just took a whole blood drawn to check some of her levels. No treatment was received for the event. The outcome of the event was recovered in Jan2021.
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test, Urticaria
Clinical narrative: Started breaking out in hives; This is a spontaneous report from a contactable consumer (patient). A 29-year-old female patient received the first dose of BNT162B2, lot number: EL0142, via an unspecified route of administration on 30Dec2020 at single dose for COVID-19 immunisation. Medical history included asthma (had an Inhaler just for whenever it's bad but she hadn't taken it in probably over a year), had typhoid once in the past as a child and had an allergy to Sulfa drugs (Unspecified Medication). The patient's concomitant medications were not reported. Patient stated she got the Vaccine on 30Dec2020 and a week later that would have been on 06Jan2021, she believed that was the date that evening she started breaking out in hives and she typically had typhoid once in the past as a child because she had an allergy to Sulfa drugs (Unspecified Medication). So she got hives a week later and she got them again three days later both in the evening and both disappeared by the time. She woke up in the morning she didn't take any antihistamines or anything. The patient wanted to know if that was a reaction other people were having and could provide any advice on second dose. She was supposed to get the second dose on the 21Jan2021. Patient stated it was twice that she had received the vaccine, she broke out with hives and it was not typically normal for her. The patient had lab testing a couple of weeks prior to the report, just took a whole blood drawn to check some of her levels. No treatment was received for the event. The outcome of the event was recovered in Jan2021.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vision blurred
Clinical narrative: Blurred vision; This is a spontaneous report from a contactable nurse (patient). A 65-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number and expiration date were not reported) on 12Jan2021 at a single dose, with route of administration unspecified, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient had received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number and expiration date were not reported) on an unspecified date for COVID-19 immunization. On 13Jan2021, the patient had blurred vision. The patient was going to an eye doctor on the day of reporting (reported as today at 1:00 PM). The outcome of the event, blurred vision, was unknown.  Information on Lot/Batch number has been requested.
Age: 89.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cerebrovascular accident, Unresponsive to stimuli
Clinical narrative: Pt received the vaccination on 1-22-21 and about 3:30 AM on 1-23-21 fell while going to bathroom, was not responsive and husband helped to sitting position, then became unresponsive and EMS was activated and brought to ER where she was found to have a large intraparenchymal right cerebral hemorrhage with large Right subdural hemorrhage, midline shift of 1.3 cm as well. Pt made comfort care and subsequently died on 1-25-21
Age: 89.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Brain midline shift, Cerebral haemorrhage, Computerised tomogram head abnormal, Death, Fall
Clinical narrative: Pt received the vaccination on 1-22-21 and about 3:30 AM on 1-23-21 fell while going to bathroom, was not responsive and husband helped to sitting position, then became unresponsive and EMS was activated and brought to ER where she was found to have a large intraparenchymal right cerebral hemorrhage with large Right subdural hemorrhage, midline shift of 1.3 cm as well. Pt made comfort care and subsequently died on 1-25-21
Age: 89.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Subdural haemorrhage, Unresponsive to stimuli
Clinical narrative: Pt received the vaccination on 1-22-21 and about 3:30 AM on 1-23-21 fell while going to bathroom, was not responsive and husband helped to sitting position, then became unresponsive and EMS was activated and brought to ER where she was found to have a large intraparenchymal right cerebral hemorrhage with large Right subdural hemorrhage, midline shift of 1.3 cm as well. Pt made comfort care and subsequently died on 1-25-21
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chest discomfort, Loss of consciousness
Clinical narrative: After about between 10 to 15 minutes of the shots, started feeling hot and cold symptoms of your about to pass out. Then tightness of chess where its hard to breath. EMS were around to give me 2 shots of Epi   one at a time with the interval of about 5 to 15 minutes. the first Epi was OK but still having hard time breathing and the second one feels a lot better but cant stop shivering's. then I was transferred to emergency room and treated also with some allergy med. (Benadryl administer through IV)
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chest discomfort, Chills, Dizziness, Dyspnoea, Feeling cold
Clinical narrative: After about between 10 to 15 minutes of the shots, started feeling hot and cold symptoms of your about to pass out. Then tightness of chess where its hard to breath. EMS were around to give me 2 shots of Epi   one at a time with the interval of about 5 to 15 minutes. the first Epi was OK but still having hard time breathing and the second one feels a lot better but cant stop shivering's. then I was transferred to emergency room and treated also with some allergy med. (Benadryl administer through IV)
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Feeling hot
Clinical narrative: After about between 10 to 15 minutes of the shots, started feeling hot and cold symptoms of your about to pass out. Then tightness of chess where its hard to breath. EMS were around to give me 2 shots of Epi   one at a time with the interval of about 5 to 15 minutes. the first Epi was OK but still having hard time breathing and the second one feels a lot better but cant stop shivering's. then I was transferred to emergency room and treated also with some allergy med. (Benadryl administer through IV)
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chest discomfort, Dizziness, Electrocardiogram, Feeling of body temperature change, Tryptase
Clinical narrative: After about between 10 to 15 minutes of the shots, started feeling hot and cold symptoms of your about to pass out. Then tightness of chess where its hard to breath. EMS were around to give me 2 shots of Epi   one at a time with the interval of about 5 to 15 minutes. the first Epi was OK but still having hard time breathing and the second one feels a lot better but cant stop shivering's. then I was transferred to emergency room and treated also with some allergy med. (Benadryl administer through IV)
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Urticaria
Clinical narrative: After about between 10 to 15 minutes of the shots, started feeling hot and cold symptoms of your about to pass out. Then tightness of chess where its hard to breath. EMS were around to give me 2 shots of Epi   one at a time with the interval of about 5 to 15 minutes. the first Epi was OK but still having hard time breathing and the second one feels a lot better but cant stop shivering's. then I was transferred to emergency room and treated also with some allergy med. (Benadryl administer through IV)
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Tachycardia
Clinical narrative: dizzy; tachycardic; This is a spontaneous report from a contactable physician (patient). A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date not reported), via an unspecified route of administration on 05Jan2021 at single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient got dizzy and tachycardic on an unspecified date. The patient asked if she should get the second dose. Clinical outcome of the events was unknown.  Information about lot/batch number has been requested.
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Paraesthesia
Clinical narrative: On 01/14/21 I  started developing neck and shoulder pain. I reported symptoms to ER. On 01/20/21 I also started developing stiffness and pain on may arms, hands and feet on both sides. I reported symptoms to Urgent Care. Since then the pain has increased and is now worse on my right hand side-arms, feet; leg-up the glutes and face. I was seen on Urgent Care on 01/22/21 and was told to take OTC ibuprofen. Since symptoms worsened I went to ED on 01/24/21 and was told to keep taking ibuprofen and follow-up with my PCP. I saw my PCP on 01/25/21 and was told to continue monitoring symptoms, continue ibuprofen and f/u in week. I was also prescribed an Hydroxyzine to help with anxiety.